跳至主要内容
临床试验/NCT03673397
NCT03673397已完成不适用

The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression: a Randomized Controlled Trial

Oberwaid AG2 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2018年9月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
92
试验地点
2
主要终点
Change from baseline in sleep efficiency (%) at follow-up assessed by polysomnography

研究概览

简要总结

The aim of this trial is to investigate the effects of a single bout of aerobic exercise on sleep in patients with depression.

详细描述

PRIMARY OBJECTIVE:

The primary objective of this study is to evaluate whether a single bout of aerobic exercise improves sleep efficiency more than a control condition in patients with depression.

SECONDARY OBJECTIVES:

Secondary objectives are to assess the effects of a single bout of aerobic exercise on 1) sleep continuity, 2) sleep architecture, 3) pre-sleep arousal, 4) subjective sleep quality, 5) daytime sleepiness, 6) nocturnal blood pressure, 7) heart rate variability, and 8) the frequency and severity of adverse events.

DESIGN:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatient psychosomatic rehabilitation in the clinic OBERWAID, St.Gallen, Switzerland
  • Age: ≥18 and ≤65 years old
  • Primary diagnosis of depression (F32, F33) without psychotic episode according to International Statistical Classification of Diseases, 10th edition

排除标准

  • Regular use of hypnotic agents (patients were included if no hypnotic agents were taken 2 weeks prior to study participation)
  • Factors precluding exercise testing or training
  • Use of beta-blockers (with the exception of Carvedilol & Nebivolol)
  • Use of opioids
  • History of epilepsy
  • Restless legs syndrome defined by ≥7 points on the restless legs syndrome screening questionnaire (RLSSQ)
  • Moderate or severe sleep apnea defined by an oxygen desaturation index (ODI) ≥15 in the first polysomnography.
  • Morbid adiposity with BMI >40

结局指标

主要结局

Change from baseline in sleep efficiency (%) at follow-up assessed by polysomnography

时间窗: Baseline (night 1) and follow-up (night 2)

Calculated as (total sleep time / total recording time) \* 100. Higher values represent a better outcome. A one-way ANCOVA will be computed with baseline sleep efficiency (%) and minimization factors as covariates, intervention as the independent variable, and follow-up sleep efficiency (%) as the dependent variable.

次要结局

  • Change from baseline in number of awakenings at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in rapid eye movement sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in sleep onset latency (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in nocturnal autonomic modulation at follow up(Baseline (night 1) and follow-up (night 2))
  • Difference in adverse events between exercise and control group(Immediately after termination of exercise intervention or control condition and after awakening from follow-up (night 2))
  • Change from baseline in stage 1 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in stage 3 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in non-rapid eye movement sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in stage shift index at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in wake after sleep onset (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in light sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in rapid eye movement sleep-latency (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in subjective sleep quality at follow-up assessed by self-rated questionnaire 'revised Schlaffragebogen A'(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in stage 2 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in pre-sleep autonomic modulation at follow-up(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in post-sleep autonomic modulation at follow-up(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in nocturnal mean arterial pressure at follow-up assessed by pulse transit time (ECG, modified lead II; fingertip photoplethysmogram, single initial calibration measurement)(Baseline (night 1) and follow-up (night 2))
  • Change from baseline in subjective pre-sleep arousal at follow-up assessed by self-rated questionnaire 'Pre-Sleep Arousal Scale'(Baseline (night 1) and follow-up (night 2))
  • State sleepiness assessed by self-rated questionnaire 'Stanford Sleepiness Scale' (SSS)(Day 5 (i.e. day after night 2): at 08:00 am, 12 noon, 04:00 pm, and 08:00 pm)

研究者

发起方
Oberwaid AG
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验